does noom prescribe semaglutide Novo Nordisk expands Wegovy access as FDA bans copies Noom dosing card for 5mg/2ml

According to the pharmaceutical industry on January 29, Roche announced the previous day the results of its Phase 2 clinical trial for CT-388, a dual agonist obesity treatment targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), and stated its intention to begin Phase 3 trials within the first quarter of this year

A study published in early 2025 found clear evidence that the share of prescriptions filled at PBM-owned pharmacies was substantially higher among patients enrolled in PBM-owned health plans, compared to patients covered by other insurers

GHK-Cu is legally sold in over-the-counter cosmetic skincare products, and cosmetics are regulated by the FDAbut they are not approved by the FDA

Lars Wilkinson is an employee of and shareholder in Novo Nordisk A/S